|
| dbGaP Submitter Subject ID (ID2) | Coriell Sample ID | Consent | Control | Gender | Race | Age | Baseline Max AMD Severity | Final Max AMD Severity |
| AR2_0274 | ED149668 | General Research Use | No | Female | White | 58 | 8 - AREDS AMD Severity Scale Step 8 | 8 - AREDS AMD Severity Scale Step 8 |
| AR2_0294 | ED148943 | General Research Use | No | Female | White | 55 | 8 - AREDS AMD Severity Scale Step 6 | 7 - AREDS AMD Severity Scale Step 7 |
| AR2_0363 | ED148374 | General Research Use | No | Male | White | 57 | 5 - AREDS AMD Severity Scale Step 5 | 5 - AREDS AMD Severity Scale Step 5 |
| AR2_1115 | ED148382 | General Research Use | No | Female | White | 59 | 6 - AREDS AMD Severity Scale Step 6 | 7 - AREDS AMD Severity Scale Step 7 |
| AR2_0066 | ED148141 | General Research Use | No | Male | White | 58 | 7 - AREDS AMD Severity Scale Step 7 | 8 - AREDS AMD Severity Scale Step 8 |
| AR2_0136 | ED149197 | General Research Use | No | Female | White | 57 | 7 - AREDS AMD Severity Scale Step 7 | 7 - AREDS AMD Severity Scale Step 7 |
| AR2_0142 | ED148483 | General Research Use | No | Male | White | 58 | 8 - AREDS AMD Severity Scale Step 6 | 11a - Neovascular AMD with definite presence of one of the following five characteristics of neovascular AMD: SSR detachment, PED, subretinal/sub-RPE hemorrhage, hard exudate, or fibrous tissue |
| AR2_1020 | ED149351 | General Research Use | No | Female | White | 58 | 7 - AREDS AMD Severity Scale Step 7 | 8 - AREDS AMD Severity Scale Step 8 |
| AR2_3261 | ED149008 | General Research Use | No | Female | White | 56 | 7 - AREDS AMD Severity Scale Step 7 | 7 - AREDS AMD Severity Scale Step 7 |
| AR2_3354 | ED149003 | General Research Use | No | Male | White | 58 | 8 - AREDS AMD Severity Scale Step 8 | 9 - AREDS AMD Severity Scale Step 9 |
| AR2_0605 | ED148280 | General Research Use | No | Female | White | 59 | 6 - AREDS AMD Severity Scale Step 6 | 7 - AREDS AMD Severity Scale Step 7 |
| AR2_2341 | ED149116 | General Research Use | No | Female | White | 55 | 7 - AREDS AMD Severity Scale Step 5 | 8 - AREDS AMD Severity Scale Step 8 |
| AR2_3029 | ED149875 | General Research Use | No | Female | White | 57 | 6 - AREDS AMD Severity Scale Step 6 | 5 - AREDS AMD Severity Scale Step 5 |
| AR2_3146 | ED148727 | General Research Use | No | Female | White | 58 | 11b - Neovascular AMD with end-stage disease (e.g., definite disciform scar, or photocoagulation scar), or two or more of the following five characteristics of neovascular AMD: SSR detachment, PED, subretinal/sub-RPE hemorrhage, hard exudate, or fibrous tissue | 11b - Neovascular AMD with end-stage disease (e.g., definite disciform scar, or photocoagulation scar), or two or more of the following five characteristics of neovascular AMD: SSR detachment, PED, subretinal/sub-RPE hemorrhage, hard exudate, or fibrous tissue |
| AR2_3283 | ED149896 | General Research Use | No | Female | White | 58 | 11b - Neovascular AMD with end-stage disease (e.g., definite disciform scar, or photocoagulation scar), or two or more of the following five characteristics of neovascular AMD: SSR detachment, PED, subretinal/sub-RPE hemorrhage, hard exudate, or fibrous tissue | 11b - Neovascular AMD with end-stage disease (e.g., definite disciform scar, or photocoagulation scar), or two or more of the following five characteristics of neovascular AMD: SSR detachment, PED, subretinal/sub-RPE hemorrhage, hard exudate, or fibrous tissue |
| AR2_4251 | ED149981 | General Research Use | Yes | Female | White | 58 | | |
| AR2_0630 | ED149206 | General Research Use | No | Male | White | 56 | 5 - AREDS AMD Severity Scale Step 4 | 7 - AREDS AMD Severity Scale Step 7 |
| AR2_0895 | ED149626 | General Research Use | No | Female | White | 58 | 11b - Neovascular AMD with end-stage disease (e.g., definite disciform scar, or photocoagulation scar), or two or more of the following five characteristics of neovascular AMD: SSR detachment, PED, subretinal/sub-RPE hemorrhage, hard exudate, or fibrous tissue | 11b - Neovascular AMD with end-stage disease (e.g., definite disciform scar, or photocoagulation scar), or two or more of the following five characteristics of neovascular AMD: SSR detachment, PED, subretinal/sub-RPE hemorrhage, hard exudate, or fibrous tissue |
| AR2_1079 | ED148737 | General Research Use | No | Female | White | 55 | 9 - AREDS AMD Severity Scale Step 8 | 9 - AREDS AMD Severity Scale Step 9 |
| AR2_2377 | ED149273 | General Research Use | No | Female | White | 59 | 8 - AREDS AMD Severity Scale Step 8 | 8 - AREDS AMD Severity Scale Step 8 |